Mushtaq Ahmad Wani, Ph.D.

Dikutip oleh

	Semua	Sejak 2020
Kutipan	133	133
indeks-h	6	6
indeks-i10	5	5

2020202120222023202420254 14 27 36 39 9

Akses publik

Lihat semua

1 artikel

0 artikel

tersedia

tidak tersedia

Berdasarkan pada mandat pendanaan

Pengarang bersama

Kuldeep K. RoyProfessor and Head (Pharma Cluster), School of Health Sciences & Technology, UPES, DehradunEmail yang diverifikasi di ddn.upes.ac.in
Prabha GargNational Institute of Pharmaceutical Education and Research, S.A.S. NagarEmail yang diverifikasi di niper.ac.in
Dr. Faheem Hyder PottooAssistant Professor (Pharmacology), College of Pharmacy, Imam Abdulrahman Bin Faisal UniversityEmail yang diverifikasi di iau.edu.sa
Anjali sharmaUniversity of California, San DiegoEmail yang diverifikasi di ucsd.edu
Arnish ChakrabortyTCG Lifesciences Pvt LtdEmail yang diverifikasi di tcgls.com
Ashis RoyUniversity of CalcuttaEmail yang diverifikasi di tcgls.com
Priyadarshi MannaUniversity of CalcuttaEmail yang diverifikasi di tcgls.com
Navneet Kumar, Ph.D.National Institute of Pharmaceutical Education and Research, S.A.S NagarEmail yang diverifikasi di niper.ac.in
Aritra BanerjeeUniversity of Tennessee, KnoxvilleEmail yang diverifikasi di vols.utk.edu
Sanskriti RaiPh.D. Student, All India Institute of Medical Sciences, New Delhi-110029, IndiaEmail yang diverifikasi di aiims.edu
Gyan ModiIIT (BHU)Email yang diverifikasi di itbhu.ac.in
Dr. Srikrishna SaripellaProfessor, Department of Biochemistry, Institute of Science, Banaras Hindu UniversityEmail yang diverifikasi di bhu.ac.in
Onkar Prakash KulkarniProfessorEmail yang diverifikasi di hyderabad.bits-pilani.ac.in
Tanmaykumar VarmaNational Institute of Pharmaceutical Education and Research, S. A. S. NagarEmail yang diverifikasi di niper.ac.in
Saroj KumarAIIMS, New Delhi & Uppsala University, SwedenEmail yang diverifikasi di lightsource.ca
Anju SharmaNPDF, National Institute of Pharmaceutical Education and Research, SAS Nagar, PunjabEmail yang diverifikasi di niper.ac.in
GAURI SHANKARPh.D, Medicinal ChemistryEmail yang diverifikasi di itbhu.ac.in
Prabhat KumarBanaras Hindu UniversityEmail yang diverifikasi di bhu.ac.in
Prof. Sharad WakodeProfessor, DIPSAR, Delhi Pharmaceutical Sciences and Research University (DPSRU)Email yang diverifikasi di dipsar.ac.in
Rahul Gajbhiye, M.B.B.S., Ph.D.ICMR-National Institute for Research in Reproductive Health, DBT Wellcome India Alliance ClinicalEmail yang diverifikasi di nirrh.res.in

Ikuti

Mushtaq Ahmad Wani, Ph.D.

Research Scientist, CSIR-Indian Institute of Integrative Medicine (CSIR-IIIM) Jammu

Email yang diverifikasi di niper.ac.in - Beranda

Computer Aided Drug Design Artificial Intelligence Bioinformatics Pharmacoinformatics


Judul Urutkan menurut kutipan Urutkan menurut tahun Urutkan menurut judul	Dikutip oleh Dikutip oleh	Tahun
Effect of environmental toxicants on neuronal functions S Sharma, S Wakode, A Sharma, N Nair, M Dhobi, MA Wani, FH Pottoo Environmental Science and Pollution Research 27, 44906-44921, 2020	48	2020
Machine learning-enabled predictive modeling to precisely identify the antimicrobial peptides MA Wani, P Garg, KK Roy Medical & Biological Engineering & Computing 59 (11), 2397-2408, 2021	21	2021
Emerging opportunities of exploiting mycobacterial electron transport chain pathway for drug-resistant tuberculosis drug discovery KK Roy, MA Wani Expert opinion on drug discovery 15 (2), 231-241, 2020	21	2020
Novel pyrimidinone derivatives show anticancer activity and induce apoptosis: Synthesis, SAR and putative binding mode A Roy, M Kundu, P Dhar, A Chakraborty, S Mukherjee, J Naskar, C Rarhi, ... ChemistrySelect 5 (15), 4559-4566, 2020	11	2020
Development and validation of consensus machine learning-based models for the prediction of novel small molecules as potential anti-tubercular agents MA Wani, KK Roy Molecular Diversity 26 (3), 1345-1356, 2022	10	2022
Targeting the cytochrome bc₁ complex for drug development in M. tuberculosis MA Wani, DK Dhaked Molecular Diversity 26 (5), 2949-2965, 2022	9	2022
An update on ATP synthase inhibitors: a unique target for drug development in M. tuberculosis LM Kelam, MA Wani, DK Dhaked Progress in Biophysics and Molecular Biology 180, 87-104, 2023	6	2023
Denouement of chemicals on amyotrophic lateral sclerosis: is green chemistry the answer F Fayaz, FH Pottoo, S Shafi, MA Wani, S Wakode, A Sharma Medicinal Chemistry 16 (8), 1058-1068, 2020	4	2020
Unlocking translational machinery for antitubercular drug development N Kumar, MA Wani, CI Raje, P Garg Trends in Biochemical Sciences 49 (3), 195-198., 2024	3	2024
Discovery of novel hybrid tryptamine-rivastigmine molecules as potent AChE and BChE inhibitors exhibiting multifunctional properties for the management of Alzheimer's disease G Shankar, P Kumar, S Rai, A Ghosh, T Varma, MA Wani, S Kumar, ... European Journal of Medicinal Chemistry 283, 117066, 2025		2025
Computer-Aided Drug Design Approaches for the Identification of Potent Inhibitors Targeting Elongation Factor G of Mycobacterium tuberculosis MA Wani, A Banerjee, P Garg Journal of Molecular Graphics and Modelling 136, 108954, 2025		2025
Predictive Modeling and Drug Repurposing for Type-II Diabetes N Wankhade, A Sharma, MA Wani, A Banerjee, P Garg ACS Medicinal Chemistry Letters 15 (11), 1907-1917, 2024		2024
Using Cryo-EM Structure of the Mycobacterial Cytochrome bcc-aa3 Supercomplex to Decrypt the Binding Mechanism of its Substrate (s) and Known Inhibitors MA Wani, KK Roy Available at SSRN 3530856, 2020		2020

Sistem tidak dapat melakukan operasi ini. Coba lagi nanti.

Artikel 1–13

Kutipan per tahun

Kutipan duplikat

Kutipan yang digabung

Tambahkan pengarang bersamaPengarang bersama

Ikuti

Dikutip oleh

Pengarang bersama